[Transfer] The seventh batch of national acquisition will open the bid immediately!A large number of pharmaceutical companies enter the situation

[Transfer] The seventh batch of national acquisition will open the bid immediately! A large number of pharmaceutical companies enter the bureau (with the latest analysis)

Source: Sai Blue/Color

01

A large number of pharmaceutical companies, catch up with the "last bus" of Guotai

Four days later, the seventh batch of countries opened the bid for Nanjing.

According to the "Gy-YD2022-1) issued by the Shanghai Joint Procurement Office of the Shanghai United Purchasing Office, companies that obtain effective domestic registration approval before July 7 (inclusive) , Can participate in this round of collection.

Recently, another group of pharmaceutical companies successfully settled in the last bus of Guotai.

In the "Drug Approval Certificate to Receive the Information Release" issued by the State Drug Administration on July 04, 2022. The four national collections in the release of films, and a group of pharmaceutical companies have successfully entered the game through consistency evaluation, involving well -known pharmaceutical companies such as Yangtze River, Ruiyang, Chen Xin, China Resources Sanjiu, Yipin, and China Resources Shuanghe Limin.

At the same time, the seventh batch of national mining competition pattern is constantly changing. Due to the epidemic and other reasons, the seventh batch of countries has slowed a lot compared to the previous batch of countries, and the number of enterprises in the bureau continues to increase, and competition is becoming increasingly fierce.

For example, according to Data from Yongzhi.com, 11 pharmaceutical companies have entered the bureau of Olympic Capsules. If Yipinhong successfully entered the game, the number of competitive companies will become 12; Enterprises enter, and now add 3 more, the number of competitive companies is changed to 18.

From the perspective of the seventh batch of national optical rules, it is still allowed to be selected up to 10 companies.

Nearly June, the seventh batch of companies in the game had reached nearly 300. Judging from the number of varieties that meet the requirements of collecting collection, Qilu involves the largest variety (17); followed by Yangtze River (14); Coron (13); stone medicine (13); Chinese creature (11); Chengdu; Chengdu; Chengdu; Chengdu; Chengdu; Chengdu; Chengdu; Beite (10) (new changes may occur recently).

Although it is less than 48 hours since the last time the "last bus" is settled in the "last bus", the number of major pharmaceutical companies has not relaxed, and the number of enterprises in the bureau is still increasing.

Dong Zecheng, the marketing director of a domestic pharmaceutical company, told the author that the enterprise that entered the bureau needs to understand the rules of the country as soon as possible and formulate a quotation strategy. Compared with other pharmaceutical companies, the whistle -entry enterprise has the advantage of post -issuing position.

Zhao Jiazhen, director of the market director of Dopple, believes that for the enterprises that enters the bureau, the first thing to do depends on the competitive pattern of their products. If the number of pharmaceutical companies entering the bureau is more than 5, the difficulty of the whistle will be much more difficult.

"At this time, the enterprise must be prepared for both hands. One is to estimate and simulate its own price, competitive prices, and possible quotations; Enterprises will kill and which companies will abandon the bid. Of course, if you choose it, you must think about the stocking area while selecting the supply area. "

02

The bid is right, how to become the "lucky child" in the middle school

According to the seventh batch of national optical documents, the confirmation time of the National Cock Supply area is at 4 pm on July 12 (Tuesday) and 9 am on July 13 (Wednesday). No. 18 Huanling Road, Xuanwu District, Nanjing).

The seventh batch of National Cai contains 61 varieties of 125 products, involving multiple large varieties with a size of over 1 billion. When the bid opening is right, how can the entry enterprise increase?

Judging from the requirements of this national collection, companies need to meet two parts of conditions at the same time. On the basis of the three conditions that meet the 1.8 -fold fuse mechanism, a decrease of 50%or more than equal to 50%, and the unit comparable price less than 0.1 yuan, it is also necessary to meet the highest level of the same variety in the same variety, or the highest variety in the same variety is the highest. Calculating the ratio of "comparable price" unit comparable price "unit comparable price" unit comparable price 'in the same variety of units in the same variety ", in this episode of the top 6 of the ratio of the ratio of all varieties (if and the No. 1 and No. 1 and No. 1 and No. 1 The 6 calculations are equal, and the 6th place is tied).

The rules are more stringent, and the highest price of the same variety that meets the first part of the condition is no longer directly selected. The quotation strategy of pharmaceutical companies needs to make great adjustments.

Dong Zecheng pointed out that the enterprise's quotation strategy depends on the cost of production; the other is to look at the competitive pattern; the third is to see its own situation, such as the market share of the product.

Zhao Jiazhen believes that for some companies with large market share, they are under greater pressure. Often, some companies with small market share admission, and change the product sales situation through a chance. The large -scale variety needs to make a key assessment based on the current competitive situation. Once the price decreases, whether it can be positively proportioned to the growth of sales, how big is the plate in the entire market.

"In addition, after the price reduction of the product, the company has to consider whether to develop the second, even the third battlefield, such as outside the courtyard," said the above person.

Of course, if the selection is the first step for the company to win the market, then think about how to accept the market.

The above -mentioned people said that all collection products need to do some core tasks of development and increase in the later period. After winning the bid, any company must think about how to use its own business capabilities, and the ability of the existing sales team or agent team to do a phased development work, and make its own products at the fastest speed to carry out its own products. Full coverage.

"After all, every region will have certain requirements for the selection of national pick -up products, such as one product and two regulations. This logic may not change much. In order to work, you can really stand in the market. "" At the same time, when the enterprise is doing the job, it must first depend on whether there is still a related space after the product is collected. Development of business channels, such as some integration, management, and finalists. If there is still a certain space, the efforts of the sales team must be strengthened in the later period, and the academic promotion work related to market key customers and VIP customers. "

The seventh batch of national acquisition will immediately bid, and the real "fighting war" of pharmaceutical companies will soon begin, and the market structure will be reshuffled.

Attachment: The seventh batch of national optical varieties competition pattern

Data/Picture Source: Evaluation Analysis System

This article is the content of Yaozhi.com reprinting. The copyright of pictures and text belongs to the original author. The purpose of reprinting is to pass more information, which does not represent the viewpoint of this platform. If the content, copyright and other issues are involved in the work, please leave a message on this platform, and we will delete it as soon as possible.

- END -